Nuclear Medicine: Page 48

Lantheus appoints new CCO

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent company Lantheus Holdings has named Paul Blanchfield as its new chief commercial officer (CCO).

January 26, 2020

ASNC, ASE win CMS recognition for ImageGuide Registry

By AuntMinnie.com staff writers

The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) announced that their ImageGuide Registry has been approved by the U.S. Centers for Medicare and Medicaid Services as a Qualified Clinical Data Registry for 2020.

January 21, 2020

NTP Radioisotopes increases Mo-99 production

By AuntMinnie.com staff writers

Emerging from a turbulent period that included an extended shutdown of its facilities, South African radioisotope producer NTP Radioisotopes said it doubled its molybdenum-99 (Mo-99) production runs last November.

January 21, 2020

Shine reports Lu-177 production milestone

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies and partners GE Healthcare and the Institute of Organic Chemistry and Biochemistry in the Czech Republic said they have produced patient dose quantities of the lutetium-177 (Lu-177) therapeutic isotope.

January 21, 2020

Report: Fujifilm makes pitch for Curium Pharma

By Wayne Forrest

In what would be its latest deal in an ongoing acquisition spree in healthcare, Fujifilm has made an offer to buy French radiopharmaceutical developer Curium Pharma in a transaction that could be valued as high as $3 billion, according to a January 14 report from Bloomberg.

January 15, 2020

LMI highlights research on PET neuroimaging tracers

By AuntMinnie.com staff writers

Berlin-based Life Molecular Imaging (LMI) is unveiling new study findings on its PET neuroimaging tracers through nine different presentations at this week's Human Amyloid Imaging meeting in Miami.

January 15, 2020

ASRT: Enrollment down for radiologic technology programs

By AuntMinnie.com staff writers

The number of students enrolling in radiologic technology programs trended downward in 2019, according to a report released by the American Society of Radiologic Technologists (ASRT).

January 14, 2020

Cu-64 DOTATATE PET could handle neuroendocrine tumors

By Wayne Forrest

PET imaging with copper-64 (Cu-64) DOTATATE could become a lower-radiation dose option for patients with suspected neuroendocrine tumors, according to the results of a phase III clinical trial published online January 10 in the Journal of Nuclear Medicine.

January 14, 2020

DOE waives export ban on highly enriched uranium

By AuntMinnie.com staff writers

The U.S. Department of Energy (DOE) is moving to allow the export of weapons-grade uranium, the same substance used to manufacture medical isotopes, such as molybdenum-99.

January 8, 2020

RadioMedix, Curium file NDA for PET agent

By AuntMinnie.com staff writers

Biotechnology firm RadioMedix and global nuclear medicine firm Curium have filed a new drug application (NDA) with the U.S. Food and Drug Administration for the firms' PET diagnostic radiopharmaceutical copper-64 (Cu-64) DOTATATE.

January 7, 2020

Navidea claims victories in legal case with former CEO

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals is claiming victories in several motions in a legal case pitting the company against its former CEO, Dr. Michael Goldberg.

January 2, 2020

Zr-89 immuno-PET could help predict cancer therapy outcomes

By Wayne Forrest

Researchers are one step closer to proving the worth of zirconium-89 (Zr-89) immuno-PET as a noninvasive approach to predict the effectiveness of therapy for cancerous tumors, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 17, 2019

Previous Page

Page 48 of 438

Next Page